Skip to main content

Table 1 Clinical characteristics of 338 patients with esophageal squamous cell carcinoma

From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy

 

N

%

Gender

 Male

227

67.16%

 Female

111

32.84%

Age Groups (year)

 31–40

11

3.26%

 41–50

72

21.30%

 51–60

127

37.57%

 61–70

111

32.84%

 71–80

17

5.03%

Smoking history

 Yes

174

51.48%

 No

164

48.52%

Alcohol history

 Yes

143

42.31%

 No

195

57.69%

Clinical TNM classification

 Stage I-II

97

28.70%

 Stage III-IV

241

71.30%

Tumor length (cm), mean (± SD)

5.96 (± 2.03)

 

Tumor location

 Upper thoracic

95

28.11%

 Middle thoracic

167

49.41%

 Lower thoracic

76

22.48%

Adverse event

 Grade ≥ 3

36

10.65%

 Grade < 3

302

89.35%